Kathy Laporte

Kathy Laporte is the current Director at 89bio. Kathy has also held positions at Bolt Biotherapeutics, Inc., D2G Oncology, Precipio, Inc., Elysium Therapeutics, Inc., and the California Institute of Regenerative Medicine. Kathy Laporte founded HealthTech Capital in January 2010 and was a Founding Partner at New Leaf Venture Partners from July 2005 to July 2011. Kathy Laporte has been in the venture capital industry since 1993 and has been a General Partner at Sprout Group since January 1993.

Kathy Laporte received their Master of Business Administration (MBA) from Stanford University Graduate School of Business and their Bachelor of Science (B.S.) in Biology from Yale University.